07:51 AM EDT, 10/15/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) reported Q3 adjusted earnings Wednesday of $1.30 per diluted share, up from $1.21 a year earlier.

An analyst polled by FactSet expected $1.30.

Net sales for the quarter ended Sept. 30 were $11.37 billion, compared with $10.64 billion a year earlier.

Analysts polled by FactSet expected $11.39 billion.

Abbott Laboratories ( ABT ) said it narrowed its 2025 adjusted earnings guidance range to between $5.12 and $5.18 per diluted share from $5.10 to $5.20 anticipated previously.

Two analysts polled by FactSet expect $5.15.

The company's shares were down 3.4% in recent Wednesday premarket activity.